These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35062853)

  • 1. The challenges of drug delivery to the esophagus and how to overcome them.
    Krause J; Brokmann F; Rosenbaum C; Weitschies W
    Expert Opin Drug Deliv; 2022 Feb; 19(2):119-131. PubMed ID: 35062853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors.
    Lim AW; Talley NJ; Walker MM; Storm G; Hua S
    Drug Deliv; 2023 Dec; 30(1):2219423. PubMed ID: 37344759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.
    Ludvigsson JF; Aro P; Walker MM; Vieth M; Agréus L; Talley NJ; Murray JA; Ronkainen J
    Scand J Gastroenterol; 2013 Jul; 48(7):808-14. PubMed ID: 23672638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.
    Liacouras CA; Wenner WJ; Brown K; Ruchelli E
    J Pediatr Gastroenterol Nutr; 1998 Apr; 26(4):380-5. PubMed ID: 9552132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a Dissolution Test System for the Biorelevant Characterization of Esophageal Applied Dosage Forms.
    Rosenbaum CM; Brokmann F; Krause J; Weitschies W
    J Pharm Sci; 2022 Jan; 111(1):62-68. PubMed ID: 34102203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EsoCap-system - An innovative platform to drug targeting in the esophagus.
    Krause J; Rosenbaum C; Grimm M; Rump A; Keßler R; Hosten N; Weitschies W
    J Control Release; 2020 Nov; 327():1-7. PubMed ID: 32781172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the real impairment on esophageal motility in patients with gastroesophageal reflux disease?
    Falcão A; Nasi A; Brandão J; Sallum R; Cecconello I
    Arq Gastroenterol; 2013 Apr; 50(2):111-6. PubMed ID: 23903620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scope of drug-induced, infectious and allergic esophageal injury.
    Geagea A; Cellier C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):496-501. PubMed ID: 18622166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies and therapeutic opportunities for the delivery of drugs to the esophagus.
    Zhang L; Russell D; Conway BR; Batchelor H
    Crit Rev Ther Drug Carrier Syst; 2008; 25(3):259-304. PubMed ID: 18540840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophagitis in children: an update on current pharmacotherapy.
    Shashidhar H; Tolia V
    Expert Opin Pharmacother; 2013 Dec; 14(18):2475-87. PubMed ID: 24138403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva transit in patients with gastroesophageal reflux disease.
    Cassiani RA; Mota GA; Aprile LR; Dantas RO
    Dis Esophagus; 2015 Oct; 28(7):673-7. PubMed ID: 25082357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
    Cury EK; Schraibman V; Faintuch S
    J Pediatr Surg; 2004 Feb; 39(2):e4-7. PubMed ID: 14966764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differencial diagnosis of gastroesophageal reflux disease -- eosinophilic esophagitis: case report].
    Franzius M; Stolte M; Porschen R
    Z Gastroenterol; 2005 Apr; 43(4):385-9. PubMed ID: 15830305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
    Munday W; Zhang X
    World J Gastroenterol; 2014 Aug; 20(30):10419-24. PubMed ID: 25132757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature.
    Newberry C; Lynch K
    Curr Gastroenterol Rep; 2017 Aug; 19(8):38. PubMed ID: 28730507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized esophageal eosinophilia: Is it an early manifestation of eosinophilic esophagitis or a subtype of gastroesophageal reflux disease?
    Abe Y; Iijima K; Ohara S; Koike T; Kikuchi R; Kato K; Shibuya D; Inomata Y; Oikawa K; Ueno Y
    Dig Endosc; 2014 May; 26(3):337-43. PubMed ID: 23895772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and etiology of eosinophilic esophagitis.
    Chehade M; Sampson HA
    Gastrointest Endosc Clin N Am; 2008 Jan; 18(1):33-44; viii. PubMed ID: 18061100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metalloproteinase-9 in patients with mild and severe forms of gastroesophageal reflux disease.
    Montiel-Jarquín ÁJ; Lara-Cisneros LGV; López-Colombo A; Solís-Mendoza HA; Palmer-Márquez ML; Romero-Figueroa MS
    Cir Cir; 2019; 87(4):436-442. PubMed ID: 31264989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China.
    Ma X; Xu Q; Zheng Y; Zhao Y; Lu J; Wang R; Li Z; Zou D; He J
    Dig Dis Sci; 2015 Jun; 60(6):1716-23. PubMed ID: 25599960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.